A significant shift in Canadian drug policy has happened, as the government permit the use of psilocybin fungi for therapeutic applications. Previously, these substances were heavily restricted, but a growing body of studies suggests they may offer relief for mental health illnesses like depression. The new policy represents a substantial step towa